What is Idiopathic Thrombocytopenic Purpura?
Idiopathic thrombocytopenic purpura (ITP), now more accurately termed immune thrombocytopenia, is an autoimmune disorder characterized by immunologic destruction of otherwise normal platelets, resulting in isolated thrombocytopenia (platelet count <100 × 10⁹/L) without other identifiable causes. 1
Core Pathophysiology
ITP involves two key mechanisms that distinguish it from the historical understanding:
- Accelerated platelet destruction: The immune system produces autoantibodies that target platelets, leading to their premature removal by the reticuloendothelial system in the spleen and liver 1
- Impaired platelet production: Contrary to older models that assumed compensatory bone marrow production, newer evidence demonstrates that platelet production is actually decreased in many ITP patients 1
This dual mechanism explains why the bone marrow cannot adequately compensate for the increased destruction rate.
Clinical Classification
ITP occurs in two forms:
- Primary ITP: Occurs in isolation without identifiable precipitating factors, representing the classic "idiopathic" presentation 1
- Secondary ITP: Associated with other conditions including:
- Autoimmune diseases (particularly antiphospholipid antibody syndrome)
- Viral infections (hepatitis C, HIV)
- Certain medications 1
Clinical Presentation
The severity spectrum ranges widely:
- Mild cases: Skin manifestations only (bruising, petechiae) 1
- Moderate cases: Bleeding gums, mucosal bleeding 2
- Severe cases: Internal bleeding, life-threatening hemorrhage 2
Important caveat: The clinical presentation can be highly variable among patients, ranging from completely asymptomatic (discovered incidentally on routine blood work) to acute severe bleeding 3, 4. This variability makes clinical assessment crucial for management decisions.
Diagnostic Approach
ITP is fundamentally a diagnosis of exclusion 3, 4. The diagnostic workup includes:
- Complete blood count showing isolated thrombocytopenia (platelet count <100 × 10⁹/L) 1
- Peripheral blood smear to exclude other causes 4
- Bone marrow examination is NOT necessary in children and adolescents with typical ITP features, even before corticosteroid therapy or splenectomy 1
- Testing for antinuclear antibodies is NOT necessary in children and adolescents 1
The guideline explicitly simplifies the diagnostic process to avoid unnecessary invasive procedures, particularly in pediatric populations where the presentation is typically straightforward 1.
Terminology Evolution
The nomenclature has evolved to reflect improved understanding:
- Originally: "Idiopathic thrombocytopenic purpura" (cause unknown)
- Later: "Immune thrombocytopenic purpura" (recognizing autoimmune mechanism)
- Currently preferred: "Immune thrombocytopenia" (since purpura is not always present) 1, 2
The abbreviation "ITP" remains standard across all naming conventions.
Epidemiology
- Affects approximately 2 per 100,000 adults 5
- Mean age of diagnosis: 50 years 5
- More common in females of childbearing age 5
- In children: typically acute presentation with potential for spontaneous remission
- In adults: more chronic course, though spontaneous remission can occur within months 5
Critical distinction: The natural history differs significantly between pediatric and adult populations, with children having better spontaneous remission rates, which influences treatment decisions 1.